D1 Receptor Expression Is Regulated by MicroRNA Acknowledgments Author Contributions The authors would like to acknowledge the assistance of Evangelia Sevadalis, Rex Vilanueva, Jeannie Banh, Nicholas Mastroianni and James Cappello in generating the various recombinant plasmids. Conceived and designed the experiments: KET DC EVK. Performed the experiments: KET DC EVK. Analyzed the data: KET EVK. Contributed reagents/materials/analysis tools: EVK. Wrote the paper: KET EVK. References 1. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG (1998) Dopamine receptors: from structure to function. Physiol Rev 78(1): 189–225. 2. Ozono R, O’Connell DP, Wang ZQ, Moore AF, Sanada H, et al. (1997) Localization of the dopamine D1 receptor protein in the human heart and kidney. Hypertension 30: 725–729. 3. Pacheco R, Prado CE, Barrientos MJ, Bernales S (2009) Role of dopamine in the physiology of T-cells and dendritic cells. J Neuroimmunol 216(1–2): 8–19. 4. Undieh AS (2010) Pharmacology of signaling induced by D1-like receptor activation. Pharmacol Therapeut 128: 37–60. 5. Hussain T, Lokhandwala MF (2003) Renal dopamine and hypertension. Exp Bio Med 228(2): 134–142. 6. Jung AB, Bennett JP (1996) Development of striatal dopaminergic function. I. Pre- and postnatal development of mRNAs and binding sites for striatal D1 (D1a) and D2 (D2a) receptors. Brain Res Dev Brain Res 94(2): 109–120. 7. Hurley MJ, Mash DC, Jenner P (2001) Dopamine D(1) receptor expression in human basal ganglia and changes in Parkinson’s disease. Brain Res Mol Brain Res 87(2): 271–279. 8. Pasuit JB, Li Z, Kuzhikandathil EV (2004) Multi-modal regulation of endogenous D1 dopamine receptor expression and function in the CAD catecholaminergic cell line. J Neurochem 89(6): 1508–1519. 9. Do T, Kerr B, Kuzhikandathil EV (2007) Brain derived neurotrophic factor regulates the expression of D1 dopamine receptors. J Neurochem 100(2): 416– 428. 10. Do T, Sun Q, Beuve A, Kuzhikandathil EV (2007) Extracellular cAMP inhibits D1 dopamine receptor expression in CAD catecholaminergic cells via A2a adenosine receptors. J Neurochem 101(3): 619–631. 11. Schambra UB, Duncan GE, Breese GR, Fornaretto MG, Caron MG, et al. (1994) Ontogeny of D1A and D2 dopamine receptor subtypes in rat brain using in situ hybridization and receptor binding. Neurosci 62(1): 65–85. 12. Brana C, Caille I, Pellevoisin C, Charron G, Aubert I, et al. (1996) Ontogeny of the striatal neurons expressing the D1 dopamine receptor in humans. J Comp Neurol 370(1): 23–34. 13. Tomassoni D, Bronzetti E, Cantalamessa F, Mignini F, Ricci A, et al. (2002) Postnatal development of dopamine receptor expression in rat peripheral blood lymphocytes. Mech Ageing Dev 123(5): 491–498. 14. Qi Y, Wang JK, McMillian M, Chikaraishi DM (1997) Characterization of a CNS cell line, CAD, in which morphological differentiation is initiated by serum deprivation. J Neurosci 17(4): 1217–1225. 15. Wang WC, Juan AH, Panebra A, Liggett SB (2011) MicroRNA let-7 establishes expression of beta2-adrenergic receptors and dynamically down-regulates agonist-promoted down-regulation. Proc Natl Acad Sci U S A 108(15): 6246– 6251. 16. Heyn J, Ledderose C, Hinske LC, Limbeck E, Mo¨hnle P, et al. (2012) Adenosine A2A receptor upregulation in human PMNs is controlled by miRNA-214, miRNA-15, and miRNA-16. Shock 37(2): 156–163. 17. Jensen KP, Covault J, Conner TS, Tennen H, Kranzler HR, et al. (2009) A common polymorphism in serotonin receptor 1B mRNA moderates regulation by miR-96 and associates with aggressive human behaviors. Mol Psychiatry 14(4): 381–389. 18. Adams BD, Furneaux H, White BA (2007) The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-alpha (ERalpha) and represses ERalpha messenger RNA and protein expression in breast cancer cell lines. Mol Endocrinol 21(5): 1132–1147. 19. Huang W, Li MD (2009) Differential allelic expression of dopamine D1 receptor gene(DRD1) is modulated by microRNA miR-504. Biol Psychiatry 65(8): 702– 705. 20. Sun Y, Varambally S, Maher CA, Cao Q, Chockley P, et al. (2011) Targeting of microRNA-142–3p in dendritic cells regulates endotoxin-induced mortality. Blood 117(23): 6172–6183. 21. Potvin S, Stip E, Sepehry AA, Gendron A, Bah R, et al. (2008) Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry 63(8): 801–808. 22. Zalcman S, Murray L, Dyck DG, Greenberg AH, Nance DM (1998) Interleukin-2 and -6 induce behavioral-activating effects in mice. Brain Res 811: 111–121. 23. Zalcman S, Savina I, Wise RA (1999) Interleukin-6 increases sensitivity to the locomotor-stimulating effects of amphetamine in rats. Brain Res 847(2): 276– 283. 24. Zalcman S, Green-Johnson JM, Murray L, Nance DM, Dyck D, et al. (1994) Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6. Brain Res 643(1–2): 40–49. 25. Nakano K, Higashi T, Hashimoto K, Takagi R, Tanaka Y, et al. (2008) Antagonizing dopamine D1-like receptor inhibits Th17 cell differentiation: preventive and therapeutic effects on experimental autoimmune encephalomy- elitis. Biochem Biophys Res Commun 373: 286–291. 26. Nakano K, Yamaoka K, Hanami K, Saito K, Sasaguri Y, et al. (2011) Dopamine induces IL-6-dependent IL-17production via D1-like receptor on CD4 naive T cells and D1-like receptor antagonist SCH-23390 inhibits cartilage destruction in a human rheumatoid arthritis/SCID mouse chimera model. J Immunol 186(6): 3745–3752. 27. Nakano K, Higashi T, Takagi R, Hashimoto K, Tanaka Y, et al. (2009) Dopamine released by dendritic cells polarizes Th2 differentiation. Int Immunol 21(6): 645–654. 28. Kipnis J, Cardon M, Avidan H, Lewitus GM, Mordechay S, et al. (2004) Dopamine, through the extracellular signal-regulated kinase pathway, down regulates CD4+CD25+ regulatory T-cell activity: implications for neurodegen- eration. J Neurosci 24(27): 6133–6143. 29. Eipper-Mains JE, Kiraly DD, Palakodeti D, Mains RE, Eipper BA, et al. (2011) microRNA-Seq reveals cocaine-regulated expression of striatal microRNAs. RNA 17(8): 1529–1543. 30. Karpa KD, Lidow MS, Pickering MT, Levenson R, Bergson C (1999) N-linked glycosylation is required for plasma membrane localization of D5, but not D1 dopamine receptors in transfected mammalian cells. Mol Pharmacol 56(5): 1071–1078. 31. Bermak JC, Li M, Bullock C, Zhou QY (2001) Regulation of transport of the dopamine D1 receptor by a new membrane-associated ER protein. Nat Cell Biol 3(5): 492–498. PLOS ONE | www.plosone.org 15 November 2012 | Volume 7 | Issue 11 | e49288